JOHNSON & JOHNSON

Holdings History for Protagonist Therapeutics, Inc - COM (PTGX)

Symbol: PTGX on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Value $	Shares	Price	All Holders
9/30/2024	25.8%	$110M	2.45M	$45.00	Q3 2024
6/30/2024	21.2%	$84.9M	2.45M	$34.65	Q2 2024
3/31/2024	1.61%	$70.9M	2.45M	$28.93	Q1 2024
12/31/2023	1.28%	$56.2M	2.45M	$22.93	Q4 2023
9/30/2023	15%	$40.9M	2.45M	$16.68	Q3 2023
6/30/2023	21%	$67.6M	2.45M	$27.62	Q2 2023
3/31/2023	18.3%	$56.3M	2.45M	$23.00	Q1 2023
12/31/2022	7.77%	$26.7M	2.45M	$10.91	Q4 2022
9/30/2022	6.08%	$20.6M	2.45M	$8.43	Q3 2022
6/30/2022	4.95%	$19.4M	2.45M	$7.91	Q2 2022
3/31/2022	11%	$58M	2.45M	$23.68	Q1 2022
12/31/2021	9.54%	$83.8M	2.45M	$34.20	Q4 2021
9/30/2021	3.81%	$43.4M	2.45M	$17.72	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.